Works by Chen, Renyin


Results: 9
    1
    2
    3
    4
    5
    6
    7
    8

    Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 8, p. 1648, doi. 10.1002/ijc.34372
    By:
    • Jin, Shuiling;
    • Zhao, Ruihua;
    • Zhou, Chuang;
    • Zhong, Qian;
    • Shi, Jianxiang;
    • Su, Chang;
    • Li, Qinglong;
    • Su, Xiaoxing;
    • Chi, Huabin;
    • Lu, Xu;
    • Jiang, Guozhong;
    • Chen, Renyin;
    • Han, Jinming;
    • Jiang, Miao;
    • Qiao, Shishi;
    • Liu, Jingjing;
    • Song, Min;
    • Song, Lijie;
    • Du, Yabing;
    • Chang, Zhiwei
    Publication type:
    Article
    9